LES Webinar: The LES Life Sciences Global Royalty Rate Survey Report

The webinar presented by leaders of the 2021 Life Science Global Royalty Rate survey will present the findings and value of the surveys to LES members. The 2021 Life Science survey follows and incorporates more than a decade of prior surveys, revealing trends in deal-making, including valuation by technology type and stage of development, detailed consideration of royalty components, milestones, sources, and more. The LES Life Sciences Global Royalty Rate surveys provide exceptional detail not found in other resources. Presenters will describe assessments of Oncology, Ophthalmology, Respiratory, Blood & Clotting, and Immunological therapies in particular, tiered vs. flat royalty variations, and comparisons of pre-and post- proof of concept valuations, among other topics. Attendees will learn where to find and how to obtain the Royalty Rate surveys, about historical data and trends in dealmaking, detailed assessments by field, stage, and license features, and utility and participation in future surveys.

Mike Perham, Ph.D., CLP, has been a member of LES since 2009, having served multiple roles on Annual Meeting Committees, as chair of the Life Science Sector leadership team, and the Young Members Council. He is currently a board member and program chair of the 2022 Annual Meeting. Mike is the Director, Innovations and External Relations at the Howard Hughes Me


Sean Sheridan, PhD, MBA, is a principal in the Life Sciences Practice at CRA. He has served as an expert witness in cases brought before federal and state courts, the Patent Trial and Appeal Board, the International Trade Commission, and arbitration tribunals. He has also provided financial consulting services for a variety of non-litigation purposes including transaction due diligence, license negotiations, and strategic decision‐making. Previously, Sean was as an assistant director at the technology transfer office at the University of Chicago where he was responsible for the evaluation, protection and licensing of university inventions and discoveries.

Members: Free

Non-Members: $69